Ziconotide vs Histatin-5
Head-to-head comparison of Ziconotide (ω-Conotoxin MVIIA (ziconotide)) and Histatin-5 (Human histatin 5) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Ziconotide | Histatin-5 |
|---|---|---|
| Category | Pain Management | Dental & Oral |
| Full Name | ω-Conotoxin MVIIA (ziconotide) | Human histatin 5 |
| Molecular Weight | 2639.1 Da | 3035 Da |
| Half-Life | approximately 4.5 hours | minutes in saliva |
| Amino Acids | 25 | 24 |
| Typical Dose | 0.5-19.2 mcg/day | 1-100 µM in research formulations |
| Route | Intrathecal | Topical/Oral rinse |
| Purity | ≥98% | ≥98% |
| Studies Count | 500 | 120 |
| Research Status | Approved | Pre-clinical |
Ziconotide Benefits
- ✓strong non-opioid analgesia
- ✓effective for refractory neuropathic pain
- ✓opioid-sparing option
- ✓intrathecal delivery allows targeted action
Histatin-5 Benefits
- ✓anti-Candida activity
- ✓biofilm suppression
- ✓mucosal wound support
- ✓oral innate immunity
Ziconotide Dosing
start 0.5 mcg/day intrathecal|titrate by 0.5 mcg/day no more than 2 times weekly|max 19.2 mcg/day in labeling
Histatin-5 Dosing
topical rinse or gel|short contact exposure|repeat applications in research protocols
Ziconotide Side Effects
- ⚠dizziness
- ⚠confusion
- ⚠ataxia
Histatin-5 Side Effects
- ⚠local irritation
- ⚠proteolytic instability
- ⚠dose-dependent cytotoxicity in vitro
Research Overview
Ziconotide
Clinical studies and post-marketing data support ziconotide as an analgesic for severe chronic pain that does not respond to conventional therapy. Research focuses on balancing analgesic efficacy with neuropsychiatric tolerability and careful dose titration.
Histatin-5
Histatin-5 is a major salivary defense peptide that can kill Candida species and influence oral microbial communities. It is also investigated for wound-healing and xerostomia-associated oral infection models.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.